Matthew Perry Strout, MD, PhD

Assistant Professor of Medicine (Hematology) and Lecturer in Molecular Biophysics and Biochemistry

Clinical Interests

  • Hematology
  • Leukemia
  • Lymphoma

Patient Care

Accepts new patients? No
Patient Type:
Referrals: Not Applicable

Patient Care Organizations

Cancer Center, Yale: Hematology Program

Hematology

Yale Medical Group

Board Certifications

  • Hematology (Internal Medicine) AB of Internal Medicine (2008)

  • Internal Medicine AB of Internal Medicine (2007)

Clinical Trials

Conditions Study Title
Unknown Sites Specimen Repository for Hematologic Diseases
Myeloid and Monocytic Leukemia A Randomized Phase III Study of Standard Cytarabine Plus Daunomycin (7+3) Therapy versus Idarubicin with High Dose Cytarabine (IA) with or without Vorinostat (IA+V) in Younger Patients with Previously Untreated Acute Myeloid Leukemia (AML)

Edit this profile

Contact Info

Matthew Perry Strout, MD, PhD
Patient Care Location
Smilow Cancer Hospital at Yale - New Haven
35 Park Street

New Haven, CT 06511
Lab Location
Strout Lab300 George Street, Ste Suite 787
New Haven, CT 06511
Mailing Address
Section of Hematology300 George Street
New Haven, CT 06511
Research Image 2

A, normal mouse spleen with normal germinal center architecture. B, Imu-Bcl6 Ung-/- Msh2-/- mice develop a diffuse large B cell lymphoma with a short latency (median survival, 6 months) and disrupted lymphoid architecture.